Overall survival (OS) in metastatic melanoma since the introduction of immunotherapy: A National Cancer Database analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e19333
Abstract: e19333Background: Metastatic melanoma historically had a very poor prognosis and survival until the utilization of immunotherapy. Ipilimumab, the first immune checkpoint (ICP) inhibitor was approve... read more here.
Keywords: melanoma; melanoma since; since introduction; metastatic melanoma ... See more keywords